If you live with inflammatory bowel disease, or worry about it, what you drink matters. A new review of many studies found that people who drink more soft beverages have a higher risk of developing inflammatory bowel disease. The same review found that drinking coffee, tea, or alcohol was linked to a lower risk. The researchers combined data from many observational studies, but they could not prove that drinks cause or prevent the disease. They only found associations. The review did not report how many people were studied or for how long. It also did not report specific amounts of drinks or safety issues. Because the studies looked at habits over time, they cannot rule out other factors that might influence risk. Still, the patterns are consistent enough to pay attention to. For people managing inflammatory bowel disease, this adds a piece to the puzzle of daily choices. It does not mean you must change your habits, but it may help you talk with your doctor about what fits your life.
Meta-analysis links soft drinks to higher IBD risk, alcohol, coffee, tea to lower riskSoft drinks linked to higher inflammatory bowel disease risk
AI-generated summary of the cited source, checked by automated accuracy review. How we work
This meta-analysis of observational studies synthesized evidence on the association between consumption of various drinks (soft beverages, alcohol, coffee, tea) and the risk of inflammatory bowel disease (IBD). The analysis pooled data from multiple studies, though specific study characteristics, sample sizes, and follow-up durations were not reported in the abstract.
Key findings showed that soft beverage intake was associated with an increased risk of IBD (OR = 1.144; 95% CI: 1.052–1.243; p = 0.002). In contrast, alcohol consumption (OR = 0.793; 95% CI: 0.629–0.999; p = 0.049), coffee intake (OR = 0.807; 95% CI: 0.667–0.976; p = 0.027), and tea intake (OR = 0.711; 95% CI: 0.522–0.970; p = 0.031) were each associated with a reduced risk of IBD. The authors noted a linear inverse dose-response for alcohol and coffee, but specific trends were not fully detailed.
Limitations include the observational nature of the included studies, precluding causal conclusions. The meta-analysis did not report on heterogeneity, publication bias, or adjustments for confounders. No safety data or practice relevance were provided.
Clinicians should interpret these associations cautiously. While the findings suggest potential dietary influences on IBD risk, they do not support recommending changes in drink consumption based solely on this evidence.